MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
6.02
+0.20 (3.44%)
Apr 25, 2025, 4:03 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
941118179132-
Upgrade
Market Cap Growth
36.79%36.79%2.32%-40.01%--
Upgrade
Enterprise Value
90975949123-
Upgrade
Last Close Price
5.827.966.988.0013.35-
Upgrade
PS Ratio
29.1634.4536.3555.35135.75-
Upgrade
PB Ratio
9.0710.723.962.953.31-
Upgrade
P/TBV Ratio
10.9512.934.243.093.38-
Upgrade
EV/Sales Ratio
27.8630.1026.4134.22126.09-
Upgrade
Debt / Equity Ratio
1.541.540.690.420.150.38
Upgrade
Asset Turnover
0.080.080.050.030.03-
Upgrade
Inventory Turnover
12.7112.717.4116.05--
Upgrade
Quick Ratio
1.811.812.654.389.937.75
Upgrade
Current Ratio
1.901.902.784.5710.057.76
Upgrade
Return on Equity (ROE)
-187.68%-187.68%-83.41%-41.14%-32.33%-92.67%
Upgrade
Return on Assets (ROA)
-43.64%-43.64%-28.44%-18.00%-15.08%-20.62%
Upgrade
Return on Capital (ROIC)
-58.41%-58.41%-34.28%-20.21%-16.43%-25.55%
Upgrade
Earnings Yield
-30.82%-26.09%-24.34%-17.32%-6.83%-
Upgrade
FCF Yield
-24.30%-20.57%-24.40%-16.76%-6.19%-
Upgrade
Buyback Yield / Dilution
-14.95%-14.95%-14.89%-307.65%-135.06%-
Upgrade
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.